Shengquan Liu - Publications

AP39 alleviates HHCY-induced myocardial remodeling by regulating FUNDC1-mediated mitochondrial dynamics via S-sulfhydration of NEDD8/CUL4B.

Journal: Frontiers in pharmacology

Published: October 21, 2025

Synthesis of Benzo[a]carbazoles via Palladium-Catalyzed Tandem Cyclization of Diarylalkynes with Isocyanides.

Journal: Organic letters

Published: June 06, 2025

The interactions and biological pathways among metabolomics products of patients with coronary heart disease.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 08, 2023

Effects of gas signaling molecule SO2 in cardiac functions of hyperthyroid rats.

Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology

Published: November 07, 2023

AP39 inhibits ferroptosis by inhibiting mitochondrial autophagy through the PINK1/parkin pathway to improve myocardial fibrosis with myocardial infarction.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 06, 2023

Gaseous signal molecule SO2 regulates autophagy through PI3K/AKT pathway inhibits cardiomyocyte apoptosis and improves myocardial fibrosis in rats with type II diabetes.

Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology

Published: July 29, 2022

Hydrogen sulfide alleviates hypothyroidism-induced myocardial fibrosis in rats through stimulating autophagy and inhibiting TGF-β1/Smad2 pathway.

Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology

Published: August 23, 2021